15th Annual Clinical Trials Summit 2024

                                                  15th Annual Clinical Trials Summit 2024

                                                                               29th & 30th May 2024, Mumbai - India

15th Annual Clinical Trials Summit 2024 will provide a platform to discuss on the futuristic advancements in Clinical Trials and clinical research. This multidisciplinary program involves broad participation of people from Clinical Trials community who are focused on learning more about clinical research, Clinical Trials planning & management. This event opens discussion of timely topics of mutual theoretical and practical interest for clinical trial investigators who are developing new drugs and biologics. This groundbreaking platform continues the conversation between business, academics, patient advocacy, and regulatory agencies to discuss new methods and solutions to statistical challenges relevant to the design and analysis of Clinical Trials collaboratively in the real world. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.

It gives us immense pleasure in welcoming you to the 15th Annual Clinical Trials Summit 2024. I wish and pray that all our efforts will be beneficial to our industries and to our country at large

DELEGATE REGISTRATION:

E-mail - bookings@virtueinsight.com or Call - + 91 44 42108101 / M - +91 9361957193

Early Bird Price ( Valid til 10th May 2024) - INR 17,000 + GST (18%) per delegate

Standard Price - INR 19,000 + GST (18%) per delegate

SPONSORS:

Silver Partner - Tech Observer, Oncquest Laboratories

Exhibitor - Clinical Research Network India, Suven Life Sciences, Clupea

We have more sponsorship opportunities available for the event, which gives you an opportunity to exhibit/booth/speak and create brand awareness. 

KEY SPEAKERS:

KAMAL K. HALDER, ADCI, Central Drug Standard Control Organisation – EZ (CDSCO)

MAYUR PARMAR, Drugs Inspector (Deputy Collector, Gujarat Government), FDA

SUYOG MEHTA, VP & Head - Medical Affairs & Clinical Research, India & Emerging Markets, Sun Pharma

ANIL KUKREJA, VP - Medical Affairs & Regulatory, AstraZeneca

SANDESH SAWANT, VP Medical Affairs & Head - Clinical Trials, Cipla

RAMESH JAGANNATHAN, Vice President, Medical Affairs, Bharat Serums and Vaccines

SHALINI MENON, Country Medical Director, South Asia, Sanofi

ANIRBAN ROY CHOWDHURY, AVP & Head- Global CoE for Clinical Data Management Biostatistics & Clinical Operations, Sun Pharma

VAIBHAV SALVI, Director & Head – Clinical Study Unit, India & South East Asia, Sanofi

RASHMI HEGDE, VP Medical Affairs, GSK

SHIRAZ KANDAWALLA, Associate Director Regulatory Affairs, Ferring Pharmaceuticals

VIPIN SETHI, Asst Vice President, Cadila

CHIRAG TRIVEDI, Global Head, Clinical Study Units (CSU) Early Operational Strategy, Sanofi

MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates

ANITHA K, Global Head Operations, GDO Data Operations, Novartis

YASMIN SHENOY, Director-Regulatory Affairs, Sanofi

ANUP PINGLE, Medical Director - Global Health Access, GSK

MUKESH GORI, Director ESP Engagement PV & PS, Novartis

MURTUZA BUGHEDIWALA, Sr. Director of MACR, Tech Observer

DIVAKAR KOLLI, Director - Development Quality Assurance, Cipla

SUCHITA MORE, Associate Director Medical Affairs, MSD

ASHWANI PANDITA, GM Quality Management & Training, Global Clinical Research Operations, Glenmark Pharmaceuticals

VIVEK GUPTA, Associate Director - Strategic Engagements & Vendor Management - Clinical & Medical Affairs, Organon

SAKSHI SHRIVASTAVA DESAI, Associate Director International PV Strategy Realization, Johnson & Johnson

DILIP PAWAR, Director & Head Clinical Development and Medical Affairs, Unichem Laboratories

KAMLESH PATEL, Head - Medical Regulatory Clinical Research & Health Tech, Lupin

ROSHAN PAWAR, Head Medical Affairs, Alkem Laboratories

KEDAR NAYAK, Head - Clinical Development, GSK

INDU NAMBIAR, Head PV, Local Patient Safety Lead, Boehringer Ingelheim

SADANAND KULKARNI, Head - Medical, Regulatory, Vigilance & Quality (South Asia), Fresenius Kabi

DEVEN BABRE, Former Director Analytics & Benchmarking, GSK

RENUKA NEOGI, Head & Deputy General Manager – Global Clinical Quality Management, Sun Pharma

PRIYA CHATTERJEE, Head Regulatory Affairs - South Asia, Bayer Pharmaceuticals

VISHVAJIT M. KARANDIKAR, Business Unit (BU) Head -Parenteral Nutrition, Fresenius Kabi

NISHITH VYAS, Associate Director, R&D Strategic Sourcing and Vendor Management, Organon

GOPINATH MADHU, Senior Client Partner, Digital & Technology, Pfizer

SANKET NEWALE, Head Medical Affairs & Business Compliance, Wockhardt

MAYUR MAYBHATE, Head Medical Affairs, Alkem Laboratories

GODHULI CHATTERJEE, Senior Medical Advisor, India-South East Asia, Sanofi

INDRANIL PURKAIT, Senior GM -Medical Affairs, Ipca Laboratories

KAVITA LAMROR, Partner, RWE & Digital Transformation, Maxis Clinical

SHRADDHA BHANGE, Senior Medical Safety Lead, Sandoz

PRAVIN GHADGE, AVP and Head - India clinical research, Sun Pharma Laboratories

SEERA DILEEP RAJU, Senior Manager - ML & AI, MSD

KUSHAL SARDA, GM & Head, Medical Affairs, Clinical Research & PV, Shalina Healthcare

VISHWAS SOVANI, Founder Director, Pharmawisdom

VANDAN TRIPATHI, Sr Brand Manager (Digital), Cipla

Plus more joining soon

KEY THEMES:

• Clinical Trials – Market Analysis: Opportunities & Challenges
• Why Decentralisation is the future of Clinical Trials?
• Decentralisation - Sustaining DCT adoption in a challenging economic environment
• Challenges and risks for launching decentralized trials
• Prioritising patients – Always placing patients first
• Improving collaboration & transparency: The need for strong sponsor-vendor relationships
• Clinical Trial Supply - What’s the new way forward?
• Innovative methods for Clinical trial design
• Inspection readiness - What to expect when you’re inspected?
• Rising opportunities & challenges for a successful clinical trial management
• How RWE / RWD is transforming Clinical Trials? Challenges & Opportunities?
• Technology & Innovation – Impacts & Improvements on Patient Experience
• Explore the Impact of DCT on clinical development & the evolution of audits
• Creating an effective clinical trial site management
• Outsourcing in clinical trials: How to build successful partnerships?
• Collaborations between CROs and the Pharmaceutical Industry
• Data Integrity and Data Management
• End-to-end strategic partnership & managing communication gap in CROs
• Ratification - New Drugs and Clinical Trial Rules 2023
• What regulatory changes & developments can help in advancement of Clinical Trials in India
• Be part of a major networking opportunity

WHO SHOULD ATTEND:

CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors and Team Leaders from the following areas:

Clinical Research & Development, Clinical Research Services, Clinical Operations, Clinical Data Management, Clinical IT, Clinical Trials , Medical Affairs, Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study Design, Safety Surveillance, Subject Recruitment, E-Clinical System

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.